Response: Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters
Clinical and Experimental Reproductive Medicine · 10.11.2026
DOI: 10.5653/cerm.2026.010461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Reproductive Medicine, online erschienen am 10.11.2026. Verfasst von Young Dong Yu. Beteiligte Einrichtung: Department of Urology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea. danielyu0714@gmail.com.
Abstract (Originalsprache)
We thank Rodarte et al. for their thoughtful and constructive comments on our study.We agree that the proposed treatment-duration thresholds warrant cautious interpretation as exploratory values rather than definitive cutoffs for clinical counseling.We have carefully considered the suggestions in their letter to clarify our study's methods and outcomes.
Autor:innen und Institutionen
- Department of Urology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea. danielyu0714@gmail.com.
- Department of Andrology, Fertility Center of CHA Bundang Medical Center, Seongnam, Republic of Korea. danielyu0714@gmail.com.
Zitieren
APA
Yu, Y. D. (2026). Response: Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters. Clinical and Experimental Reproductive Medicine. https://doi.org/10.5653/cerm.2026.010461
Vancouver
Yu YD. Response: Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters. Clinical and Experimental Reproductive Medicine. 2026. doi:10.5653/cerm.2026.010461
BibTeX
@article{Yu2026,
author = {Yu, Young Dong},
title = {Response: Long-term use of dutasteride to treat androgenic alopecia in young men may lead to persistent abnormalities in semen parameters},
journal = {Clinical and Experimental Reproductive Medicine},
year = {2026},
doi = {10.5653/cerm.2026.010461}
}
EUVIMED